nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.132	0.365	CbGeAlD
Lofexidine—HTR1A—forebrain—Alzheimer's disease	0.0345	0.0954	CbGeAlD
Lofexidine—HTR1A—telencephalon—Alzheimer's disease	0.0317	0.0877	CbGeAlD
Lofexidine—ADRA2A—forebrain—Alzheimer's disease	0.0242	0.0669	CbGeAlD
Lofexidine—ADRA2A—telencephalon—Alzheimer's disease	0.0222	0.0615	CbGeAlD
Lofexidine—HTR1A—nervous system—Alzheimer's disease	0.0187	0.0518	CbGeAlD
Lofexidine—HTR1A—central nervous system—Alzheimer's disease	0.018	0.0499	CbGeAlD
Lofexidine—HTR1A—cerebellum—Alzheimer's disease	0.0176	0.0487	CbGeAlD
Lofexidine—HTR1A—brain—Alzheimer's disease	0.0143	0.0396	CbGeAlD
Lofexidine—ADRA2A—nervous system—Alzheimer's disease	0.0131	0.0363	CbGeAlD
Lofexidine—ADRA2A—central nervous system—Alzheimer's disease	0.0126	0.0349	CbGeAlD
Lofexidine—ADRA2A—cerebellum—Alzheimer's disease	0.0124	0.0342	CbGeAlD
Lofexidine—ADRA2A—brain—Alzheimer's disease	0.01	0.0277	CbGeAlD
Lofexidine—ADRA2A—Hemostasis—INPP5D—Alzheimer's disease	0.00138	0.00216	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.00138	0.00216	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TF—Alzheimer's disease	0.00136	0.00213	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—APP—Alzheimer's disease	0.00136	0.00213	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.00135	0.00211	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	0.00134	0.00209	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ATP5A1—Alzheimer's disease	0.00133	0.00208	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GAL—Alzheimer's disease	0.00133	0.00208	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CDK5—Alzheimer's disease	0.0013	0.00204	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TTR—Alzheimer's disease	0.00129	0.00203	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.00129	0.00202	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.00129	0.00201	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PLD3—Alzheimer's disease	0.00127	0.00199	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR6—Alzheimer's disease	0.00126	0.00197	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—GAB2—Alzheimer's disease	0.00125	0.00195	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HSD17B10—Alzheimer's disease	0.00122	0.00191	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—APP—Alzheimer's disease	0.00121	0.0019	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.00118	0.00185	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP46A1—Alzheimer's disease	0.00117	0.00183	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	0.00117	0.00183	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00115	0.00181	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GAL—Alzheimer's disease	0.00115	0.0018	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—NPY—Alzheimer's disease	0.00115	0.0018	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.00115	0.0018	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CCR5—Alzheimer's disease	0.00114	0.00179	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.00114	0.00179	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PYY—Alzheimer's disease	0.00113	0.00177	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ND1—Alzheimer's disease	0.00113	0.00177	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR2A—Alzheimer's disease	0.00112	0.00175	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CRH—Alzheimer's disease	0.00111	0.00174	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.0011	0.00173	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—NPS—Alzheimer's disease	0.00105	0.00165	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GAL—Alzheimer's disease	0.00104	0.00163	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—NPY—Alzheimer's disease	0.00104	0.00163	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IAPP—Alzheimer's disease	0.00104	0.00162	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TTR—Alzheimer's disease	0.00102	0.00159	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.00101	0.00158	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CRH—Alzheimer's disease	0.00101	0.00158	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.001	0.00157	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—SST—Alzheimer's disease	0.001	0.00157	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SOD1—Alzheimer's disease	0.000989	0.00155	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDK5—Alzheimer's disease	0.000981	0.00154	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—F2—Alzheimer's disease	0.00098	0.00154	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—APP—Alzheimer's disease	0.000976	0.00153	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—NPS—Alzheimer's disease	0.000953	0.00149	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000949	0.00149	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR6—Alzheimer's disease	0.000944	0.00148	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IGF2—Alzheimer's disease	0.00094	0.00147	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000921	0.00144	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—SST—Alzheimer's disease	0.000909	0.00143	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000909	0.00143	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—NPY—Alzheimer's disease	0.000902	0.00141	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000901	0.00141	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CCR5—Alzheimer's disease	0.000898	0.00141	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000897	0.0014	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000889	0.00139	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PYY—Alzheimer's disease	0.000889	0.00139	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—APP—Alzheimer's disease	0.000886	0.00139	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000878	0.00138	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CCL2—Alzheimer's disease	0.000873	0.00137	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CRH—Alzheimer's disease	0.00087	0.00136	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PSENEN—Alzheimer's disease	0.000857	0.00134	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PRKCG—Alzheimer's disease	0.000847	0.00133	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APH1A—Alzheimer's disease	0.000845	0.00132	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000836	0.00131	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000825	0.00129	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000823	0.00129	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—NPY—Alzheimer's disease	0.000819	0.00128	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000814	0.00128	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LRP1—Alzheimer's disease	0.000803	0.00126	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CRH—Alzheimer's disease	0.00079	0.00124	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000787	0.00123	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—SST—Alzheimer's disease	0.000787	0.00123	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	0.000784	0.00123	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	0.000784	0.00123	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDK5—Alzheimer's disease	0.000771	0.00121	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—F2—Alzheimer's disease	0.00077	0.00121	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—APP—Alzheimer's disease	0.000767	0.0012	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	0.000765	0.0012	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—NPS—Alzheimer's disease	0.000749	0.00117	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000746	0.00117	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR6—Alzheimer's disease	0.000742	0.00116	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PLAU—Alzheimer's disease	0.000741	0.00116	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—CALM1—Alzheimer's disease	0.000733	0.00115	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TPI1—Alzheimer's disease	0.000729	0.00114	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CHAT—Alzheimer's disease	0.000729	0.00114	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000724	0.00113	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—CAV1—Alzheimer's disease	0.000723	0.00113	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—SST—Alzheimer's disease	0.000715	0.00112	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000715	0.00112	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	0.000702	0.0011	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MAOB—Alzheimer's disease	0.000699	0.00109	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—APP—Alzheimer's disease	0.000697	0.00109	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	0.000691	0.00108	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—F2—Alzheimer's disease	0.000689	0.00108	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CCL2—Alzheimer's disease	0.000686	0.00108	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000681	0.00107	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS2—Alzheimer's disease	0.00068	0.00107	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PSENEN—Alzheimer's disease	0.000674	0.00106	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GAPDH—Alzheimer's disease	0.000672	0.00105	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000669	0.00105	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APH1A—Alzheimer's disease	0.000664	0.00104	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000657	0.00103	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—A2M—Alzheimer's disease	0.000649	0.00102	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000647	0.00101	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000645	0.00101	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000632	0.00099	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LRP1—Alzheimer's disease	0.000631	0.000988	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000618	0.000969	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GAL—Alzheimer's disease	0.000616	0.000965	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GFAP—Alzheimer's disease	0.000616	0.000965	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	0.000616	0.000965	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	0.000612	0.000959	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IGF1—Alzheimer's disease	0.000603	0.000945	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	0.000594	0.000931	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000586	0.000918	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000574	0.000899	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ACHE—Alzheimer's disease	0.000565	0.000885	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	0.000563	0.000882	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00056	0.000878	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—INPP5D—Alzheimer's disease	0.000558	0.000875	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	0.000554	0.000868	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000552	0.000865	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	0.000547	0.000857	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	0.000543	0.000851	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SST—Alzheimer's disease	0.000537	0.000842	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	0.000537	0.000842	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000537	0.000842	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000535	0.000839	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000535	0.000838	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000533	0.000835	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ENO1—Alzheimer's disease	0.000529	0.000829	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	0.000529	0.000829	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000526	0.000824	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APP—Alzheimer's disease	0.000524	0.00082	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	0.000519	0.000813	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000507	0.000795	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	0.000503	0.000788	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000496	0.000778	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000494	0.000774	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—BCHE—Alzheimer's disease	0.000492	0.000771	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	0.000488	0.000764	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000486	0.000762	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	0.000484	0.000758	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	0.000481	0.000754	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	0.000467	0.000732	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	0.000464	0.000728	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	0.000461	0.000722	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000461	0.000722	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000458	0.000718	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000451	0.000706	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	0.00045	0.000705	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	0.00045	0.000705	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000448	0.000702	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	0.000443	0.000694	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00044	0.00069	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	0.000435	0.000682	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000434	0.00068	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	0.000426	0.000667	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	0.000422	0.000662	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000422	0.000662	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	0.000422	0.000662	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000421	0.000659	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000419	0.000656	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	0.000412	0.000645	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	0.000405	0.000635	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	0.000395	0.000619	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	0.000394	0.000618	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000392	0.000614	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000388	0.000608	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	0.000388	0.000608	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	0.000386	0.000605	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	0.000376	0.000589	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000372	0.000584	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000365	0.000573	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	0.000362	0.000568	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	0.000362	0.000567	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	0.00036	0.000564	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	0.000356	0.000558	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000354	0.000554	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LPL—Alzheimer's disease	0.000353	0.000553	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000352	0.000552	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	0.000346	0.000542	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	0.000339	0.000531	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	0.000335	0.000524	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	0.000319	0.000499	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	0.000318	0.000498	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	0.000316	0.000495	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	0.000315	0.000494	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	0.000315	0.000494	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	0.000312	0.000489	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000308	0.000483	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	0.000301	0.000471	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	0.000298	0.000467	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	0.000297	0.000466	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—F2—Alzheimer's disease	0.000297	0.000465	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOE—Alzheimer's disease	0.000296	0.000464	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	0.000295	0.000463	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	0.000293	0.00046	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000293	0.000459	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000291	0.000455	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000287	0.00045	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	0.00028	0.000438	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	0.000273	0.000427	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	0.000272	0.000426	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	0.000271	0.000424	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—INS—Alzheimer's disease	0.000269	0.000422	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	0.000266	0.000417	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	0.000265	0.000415	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	0.00026	0.000408	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	0.000258	0.000404	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—INS—Alzheimer's disease	0.000253	0.000396	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	0.000251	0.000394	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	0.000248	0.000389	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	0.000248	0.000388	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	0.000248	0.000388	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	0.000245	0.000384	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	0.000236	0.00037	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	0.000236	0.00037	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	0.000233	0.000366	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000228	0.000358	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	0.000222	0.000348	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	0.000214	0.000336	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	0.000213	0.000333	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	0.000211	0.000331	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	0.000208	0.000326	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	0.000205	0.000321	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	0.000203	0.000318	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000202	0.000317	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	0.0002	0.000314	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	0.000199	0.000312	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	0.000185	0.000291	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	0.000184	0.000289	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	0.000184	0.000288	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	0.00017	0.000266	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000159	0.000249	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	0.000157	0.000247	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	0.000156	0.000245	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	0.000156	0.000244	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	0.000145	0.000227	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	0.000144	0.000226	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	0.000134	0.000209	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	0.000128	0.000201	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	0.000123	0.000192	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	0.000118	0.000184	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	0.000108	0.00017	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	0.000102	0.00016	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	0.000101	0.000158	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	9.24e-05	0.000145	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	8.53e-05	0.000134	CbGpPWpGaD
